Novartis Strikes Kymriah Outcome-Based Deal With German Insurers

Novartis and German insurers have agreed a payment by outcomes deal for its CAR-T therapy Kymriah.

GermanFlag
Novartis agrees a payment by outcomes deal in Germany For Kymriah

More from Europe

More from Geography